Work

BRCA/HRD genetic status does not increase toxicity to PARP inhibitors or next-line cytotoxic chemotherapy in women with epithelial ovarian cancer (479)

Year: 2022

Type: article

Study design: Observational Study

Source: Gynecologic Oncology

DOI: 10.1016/s0090-8258(22)01700-0

Authors: Alyssa Wield, Alicia Liu, Christine McGough, Jessica Berger, Michelle Boisen, Lan Coffman, Robert Edwards, Madeleine Courtney-Brooks, Jamie Lesnock, Alexander Olawaiye, Paniti Sukumvanich, Ronald Buckanovich, Haider Mahdi, Sarah Taylor

Institutions: Magee-Womens Hospital, University of Pittsburgh, University of Pittsburgh Medical Center, UPMC Hillman Cancer Center

Language: English

Topic: PARP inhibition in cancer therapy

Subfield: Oncology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W4295235035

FWCI:

Cites:

Cited by:

Related to: 10